Drugs / BI 765128
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04919499 | Jul 2021 → Aug 2023 | diabetic retinopathy | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 765128 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04919499 ↗ |
| Route | Intravitreal | “received one single intravitreal injection of low-dose BI 765128.” NCT04919499 ↗ |